Accessibility Accessibility icon
CONSULTATION (303) 951-5829
Accent Image
Looking for more Upper Pole Fullness?  Check out the new INSPIRA Breast Implant!

Looking for more Upper Pole Fullness? Check out the new INSPIRA Breast Implant!

Looking for more Upper Pole Fullness?  Check out the new INSPIRA Breast Implant!

July 6, 2015

IMG_5993As a national leader in breast augmentation, this past Friday we were honored to be chosen by Allergan to be one of the first in the nation to try out their new high projection breast implant, INSPIRA breast implants. This implant addresses one of the most critical goals of most breast implant patients–the need for more volume to the upper pole of the breast.

One of the most common concerns that my breast enhancement patients have is how to increase fullness to the upper part of their breasts without going with an excessively large implant.  In the past, the only option was to use a much larger implant to redistribute volume and expand the upper breast.  But the problem with this is that many patients didn’t want to go so big and so they were left with a result that was a little less satisfactory and were effectively stuck between the proverbial rock and a hard place when it came to making a choice for their implants.  Now, this issue may be better addressed.

To gain more upper pole fullness, the new INSPIRA implants are designed with a slightly narrower width but with greater projection.  This design allows for the breast tissue to be filled with more projection but without the need for an excessively wide base.

IMG_5999We will be posting several patient examples in the coming months and encourage you to call us to learn more about this exciting new option.  And, by combining this new look with our Summer Breast Augmentation Special, and you could be in for an even better look at an even better price.

For a limited time, CLICK HERE to schedule your consultation or call us at 303.708.8235.

Thanks again for your continued support.  We look forward to working with you.

Visualize your NEW LOOK in 3D NOW

START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Natrelle® Breast Implants are for breast augmentation and revision surgery in women at least 22 years old for silicone-filled implants and women at least 18 years old for saline-filled implants.

You should not get breast implants if you currently have an active infection, untreated breast cancer or precancer, or are pregnant or nursing. Tell your doctor about any conditions you have, any medications you are taking, and any planned cancer treatments. Breast implantation is likely not a one-time surgery.

Having implants removed and not replaced may lead to permanent cosmetic changes of the breasts. Breast implants may affect breastfeeding. Gel implants may rupture without symptoms, so periodic imaging after surgery is recommended.

Key complications are reoperation, implant removal, implant rupture, implant deflation with saline-filled implants, and severe capsular contracture.

Talk to your doctor for more information.

The use of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

Visualize your
NEW LOOK in 3D NOW!

Start now
START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.